Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Publication year range
1.
Rev. bras. plantas med ; 17(3): 385-391, Jul-Sep/2015. tab, graf
Article in Portuguese | LILACS | ID: lil-752546

ABSTRACT

RESUMO As duas espécies de espinheira-santa Maytenus aquifolium Mart. e Maytenus ilicifolia Mart. ex Reissek pertencentes à família Celastraceae e têm sido intensamente exploradas nas populações nativas devido seu alto valor medicinal. O grande interesse pela espinheira-santa é para o tratamento de gastrites, úlceras gástricas e duodenais. O efeito antiulcerogênico está relacionado com a presença de polifenóis totais, mais especificamente com os taninos. Este trabalho teve como objetivo comparar o teor de taninos entre essas duas espécies cultivadas no Horto Medicinal do Refúgio Biológico Bela Vista - RBBV da Itaipu Binacional no município de Foz do Iguaçu, PR - Brasil. Foram realizadas duas coletas com intervalo de um mês para cada espécie e para a quantificação foi realizada a análise por espectrofotometria segundo a Farmacopeia Brasileira V. Os resultados foram analisados através do teste de variância (ANOVA) e a diferença no teor de taninos foi evidenciada pelo teste Tukey, a 5% de nível de significância empregando-se o software SISVAR. Foram obtidos em média 0,61% para o lote 1 e 2 de Maytenus aquifolium e (3,90%) para Maytenus ilicifolia, resultando em uma média de 84,35% de taninos a mais para Maytenus ilicifolia em comparação com Maytenus aquifolium concluindo assim que as espécies não devem ser intercambiáveis.


ABSTRACT The two species of (espinheira-santa) Maytenus aquifolium and Maytenus ilicifolia, which belong to the Celastraceae family, have been intensively explored in native populations, due to its medicinal potential. The great interest in the espinheira-santa is due to its effectiveness on the treatment of gastritis, gastric and duodenal ulcers. The antiulcerogenic effect is related to the presence of phenolic compounds, more specifically the tannins. This study aimed to compare the tannin doses between these two species grown in the Medicinal Garden of Bela Vista Biological Refuge - RBBV of Itaipu in the city of Foz do Iguaçu, PR - Brazil. Two trials were conducted with one month interval, for the quantification of the tannins by a spectrophotometry, according to the Brazilian Pharmacopoeia V. The results were analyzed through the analysis of variance (ANOVA) and the difference in the tannins doses was demonstrated in a Tukey test at 5% level of significance employing the SISVAR software. It were found 0.61% of tannins for lot 1 and 2 of Maytenus aquifolium, and 3.90% for Maytenus ilicifolia, which represents 84.35% more tannin at Maytenus ilicifolia than at Maytenus aquifolium. Therefore, the species should not be interchanged.


Subject(s)
Tannins/administration & dosage , Maytenus/anatomy & histology , Spectrophotometry/methods , Polyphenols/pharmacology , Gastritis/prevention & control
2.
(East. Mediterr. health j).
in English | WHO IRIS | ID: who-118367

ABSTRACT

Access to family planning [FP], quality of care and exploring barriers to utilization of services are key factors in the adoption and continuation of contraception in Egypt. We conducted this study to explore the barriers affecting utilization of FP as well as the characteristics of women who discontinue using FP and nonusers of the FP services. A descriptive cross-sectional research design was used. A multistage random selection of 8 family health centres in Menufia Governorate, Egypt was done. We selected a purposive sample of 500 married, rural women of reproductive age who fulfilled the required criteria [109 non-users, 391 discontinued]. Cognitive barriers were cited by more than 55% of the participants in both groups and cultural barriers by 40% of both groups. Barriers related to the method were cited by 35.8% of the women who had discontinued, and demographic barriers by 39.4% of the non-users


Subject(s)
Rural Population , Cross-Sectional Studies , Cognition , Attitude , Regression Analysis , Family Planning Services
3.
Acta Physiol (Oxf) ; 204(3): 308-16, 2012 Mar.
Article in English | MEDLINE | ID: mdl-21992594

ABSTRACT

Renal ischaemia/reperfusion (I/R) injury is a common problem that occurs when blood flow is interrupted to the kidney in case of kidney transplantation, aortic cross-clamping and shock with subsequent resuscitation. Renal I/R injury is a complex conditions which includes the onset of an inflammatory process, which is associated with impairment of concentrating ability of the kidney and impairment of solute transport. Characteristically, renal I/R injury is associated with marked reduction in the protein expression of renal aquaporins (AQPs) mainly (AQP1, AQP2 and AQP3), and solute transporters were observed in this condition and could account for the impaired urinary concentration that observed in this condition. Recently, many agents were tested for a possible protective effect against this insult such as erythropoietin (EPO), α-melanocyte-stimulating hormone (α-MSH) and α-lipoic acid which were proved to prevent downregulation of AQPs and solute transporters. The aim of this short review is to outline the potential pathophysiological role of AQPs in renal I/R injury and to put a spotlight on the modulation of renal functions impairment in renal ischaemia by new drugs that prevent downregulation of AQPs.


Subject(s)
Aquaporins/metabolism , Kidney/blood supply , Kidney/metabolism , Reperfusion Injury/metabolism , Animals , Cytoprotection , Glomerular Filtration Rate , Hemodynamics , Humans , Kidney/drug effects , Kidney/pathology , Kidney/physiopathology , Kidney Concentrating Ability , Protective Agents/pharmacology , Reperfusion Injury/pathology , Reperfusion Injury/physiopathology , Reperfusion Injury/prevention & control
4.
Bone Marrow Transplant ; 42 Suppl 1: S89-S91, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18724314

ABSTRACT

Bone marrow and stem cell transplantation in Jordan has been performed since the 1990s, but the first comprehensive program was established at King Hussein Cancer Center (KHCC) in March 2003. The program, in addition to other health care institutions in Amman, serves approximately 5.6 million Jordanians. Also, we treat several patients per year from neighboring Arab countries. The program at KHCC performs an average of 80 transplants per year. During the past 4 years 320 patients received transplants at KHCC; 26% of them received an autologous graft and 74% allogeneic grafts. Of the allogeneic grafts 91% were taken from matched family members, 6.7% were haploidentical from one of the parents, and 2.3% were from an unrelated donor or umbilical cord blood. The actuarial overall survival among all patients has been around 65%. The most common indication for transplantation at KHCC was leukemia/MDS followed by benign nonmalignant hematological/immune deficiency/metabolic disorders, with thalassemia major being the most common among this group. The cost of SCT is variable and depends on many factors including the type of transplant and the attending post-transplant complications. The average charge for autologous transplant (both adults and pediatrics) is 24,695 JD (one JD equals 1.42 USD), and the average charge for allogeneic transplant (both adults and pediatrics) excluding haploidentical transplant is 46,787 JD. We have not noticed any peculiar patterns of complications following BMT; however, we have seen a high incidence of chronic GVHD following minitransplant with fludarabine and single-dose TBI (Seattle protocol). At the inception of the program, invasive fungal infection mainly related to building construction, and central line complications were significant. Measures implemented to control such complications were successful to a large extent. We report our results to the EBMT group and we are accredited as an unrelated transplantation center. Although from a young program, our group has presented abstracts to international conferences.


Subject(s)
Bone Marrow Transplantation , Hematopoietic Stem Cell Transplantation , Bone Marrow Transplantation/mortality , Hematopoietic Stem Cell Transplantation/mortality , Humans , Jordan
SELECTION OF CITATIONS
SEARCH DETAIL
...